Issue 3, 2019

Fluorine substituted methoxyphenylalkyl amides as potent melatonin receptor agonists

Abstract

A series of fluorine substituted methoxyphenylalkyl amides were prepared with different orientations of the fluorine and methoxy groups with respect to the alkylamide side chain and with alkyl sides of differing lengths (n = 1–3). β-Dimethyl and α-methyl derivatives were also synthesised. The compounds were tested as melatonin agonists and antagonists using the pigment aggregation of Xenopus melanophores as the biological assay. A number of these compounds were potent melatonin agonists, the potency depending on the length of the alkyl chain, the orientation of the methoxy and fluorine substituents, the amide chain length and, for the ethyl side-chain analogues, the presence of β-substituents.

Graphical abstract: Fluorine substituted methoxyphenylalkyl amides as potent melatonin receptor agonists

Supplementary files

Article information

Article type
Research Article
Submitted
07 Dec 2018
Accepted
10 Feb 2019
First published
11 Feb 2019

Med. Chem. Commun., 2019,10, 460-464

Fluorine substituted methoxyphenylalkyl amides as potent melatonin receptor agonists

A. Tsotinis, R. Kompogennitaki, I. Papanastasiou, P. J. Garratt, A. Bocianowska and D. Sugden, Med. Chem. Commun., 2019, 10, 460 DOI: 10.1039/C8MD00604K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements